Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
11.95
23.81
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Jiangsu Kanion Pharmaceutical Co Ltd stock under the Base Case scenario is 25.41 CNY. Compared to the current market price of 14.31 CNY, Jiangsu Kanion Pharmaceutical Co Ltd is Undervalued by 44%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Jiangsu Kanion Pharmaceutical Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Jiangsu Kanion Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Jiangsu Kanion Pharmaceutical Co Ltd
Balance Sheet Decomposition
Jiangsu Kanion Pharmaceutical Co Ltd
Current Assets | 3.9B |
Cash & Short-Term Investments | 2.3B |
Receivables | 1B |
Other Current Assets | 612.1m |
Non-Current Assets | 3.2B |
Long-Term Investments | 15.3m |
PP&E | 2.7B |
Intangibles | 413.4m |
Other Non-Current Assets | 60m |
Current Liabilities | 1.6B |
Accounts Payable | 230.9m |
Accrued Liabilities | 1.1B |
Other Current Liabilities | 277.8m |
Non-Current Liabilities | 345.4m |
Other Non-Current Liabilities | 345.4m |
Earnings Waterfall
Jiangsu Kanion Pharmaceutical Co Ltd
Revenue
|
4.6B
CNY
|
Cost of Revenue
|
-1.3B
CNY
|
Gross Profit
|
3.3B
CNY
|
Operating Expenses
|
-2.8B
CNY
|
Operating Income
|
479.5m
CNY
|
Other Expenses
|
47m
CNY
|
Net Income
|
526.4m
CNY
|
Free Cash Flow Analysis
Jiangsu Kanion Pharmaceutical Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Jiangsu Kanion Pharmaceutical Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
Jiangsu Kanion Pharmaceutical Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Jiangsu Kanion Pharmaceutical Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Jiangsu Kanion Pharmaceutical Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Jiangsu Kanion Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Jiangsu Kanion Pharmaceutical Co Ltd is 25.68 CNY with a low forecast of 23.23 CNY and a high forecast of 29.49 CNY.
Dividends
Current shareholder yield for Jiangsu Kanion Pharmaceutical Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Jiangsu Kanion Pharmaceutical Co., Ltd. engages in the manufacturing and sale of Chinese patent medicine preparations and health products. The company is headquartered in Lianyungang, Jiangsu and currently employs 5,045 full-time employees. The company went IPO on 2002-09-18. The firm provides capsules, oral liquid, granules, electuary, tablets, pills, patch and injections. The firm's products are applied in gynecology, orthopedics, cardiovascular and cerebrovascular, anti-infective, anti-tumor and others. The firm distributes its products mainly within domestic markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Jiangsu Kanion Pharmaceutical Co Ltd stock under the Base Case scenario is 25.41 CNY.
Compared to the current market price of 14.31 CNY, Jiangsu Kanion Pharmaceutical Co Ltd is Undervalued by 44%.